New York Awards $25 Million to Life Science Startups and Researchers

The New York State Biodefense Commercialization Fund has awarded over $25 million to 11 startups and 16 academic institutions. This funding supports research and commercialization of innovations addressing infectious disease threats, including COVID-19.

$3 Million for Rapid Diagnostics and Surveillance

The third round of the Biodefense Commercialization Fund has approved four new grants totaling over $3 million. These grants focus on rapid diagnostics and surveillance tools, keeping New York at the forefront of infectious disease discovery.

Leading in Infectious Disease Discovery

New York State is dedicated to leading in infectious disease discovery. A state representative stated, "These awards will continue to attract significant jobs and investments."

Hope Knight, President, CEO, and Commissioner of Empire State Development, highlighted the fund's benefits, including job creation and growth in the life science sector.

Round Three Awardees

The third round of funding includes:

• Rover Diagnostics: $1.8 million for an adaptable NAAT platform for rapid diagnostics.
• Icahn School of Medicine at Mount Sinai: $498,365 for a tool to monitor antibiotic resistance.
• Columbia University: $500,000 for a tool to enhance rapid diagnosis and detection of antimicrobial resistance.
• Niagara University: $261,488 to develop Cholestosome technology for a general antiviral therapeutic.

Economic and Health Impact

Since September 2021, the Biodefense Commercialization Fund has driven significant economic and health benefits. Awardees have secured over $359 million in external funding, created 22 jobs, and filed 22 patent applications, demonstrating the program's positive impact.

A Strong Future for Life Sciences in New York

New York State's $620 million Life Science Initiative aims to establish a world-class research cluster. This includes $320 million for strategic programs to attract new technologies, promote investments, and expand businesses in life sciences.

By investing in facilities, talent, and expertise, New York aims to increase industry-funded research and support academic research commercialization, fostering advanced technologies and strengthening regional economies.